Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117358) titled 'A Study comparing two Allergy Medications for Chronic hives and there effects on body Inflammation and Sleep Quality' on Sept. 9.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: UCMS IMRG
Condition:
Health Condition 1: L509- Urticaria, unspecified
Intervention:
Intervention1: Levocetrizine: 5 mg once daily orally for 8 weeks
Intervention2: Nil: Nil
Control Intervention1: Fexofenadine: 180 mg once daily...